In 2024, Martin Shkreli Net Worth is $70 Million. In This Article, We Will Learn About Martin Shkreli’s Net Worth, Earnings, Source of Income, Salary and Wealth.
Martin Shkreli is an American Financial criminal also businessman. He is known as the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare. He is the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals. He is the former CEO of the start-up software company Gödel Systems.
Martin Shkreli Net Worth
Martin Shkreli net worth is $70 Million. He worked as a financial analyst for Intrepid Capital Management and UBS Wealth Management, after 4 years as an associate at Cramer Berkowitz. He had made a 2.6 million USD bet via Lehman Brothers that the market would go down. He became the 23rd name on the Forbes ’30 under 30′ finance list in 2012.
Who Is Martin Shkreli?
Martin Shkreli was born on 17 March 1983 to his Parents Mr.Shkreli (Father) and Mrs.Shkreli(Mother). Shkreli’s Parents Immigrated to the United States. His Parents worked as Janitors. He has two sisters and one Brother their names are under review. He completed his schooling at Hunter College High School and City-As-School High School. He completed his graduation from Baruch College in 2004.
| Net Worth | $70 Million |
| Date Of Birth | 17 March 1983 |
| Birth Place | Brooklyn, New York, United States |
| Age | 41 years |
| Profession | American Businessman |
| Nationality | American |
| Zodiac Sign | Pisces |
| Father | Mr.Shkreli |
| Mother | Mrs.Shkreli |
| Sister | Two Sister |
| Brother | One Brother |
| Girlfriend | Christie Smythe and Madison Campbell (Ex) |
| Eye Color | Black |
| Hair Color | Black |
Martin Shkreli Net Worth In the Last Four Years
| Year | Martin Shkreli’s Net Worth |
| 2023 | $ 50 Million |
| 2022 | $ 40 Million |
| 2021 | $30 Million |
| 2020 | $20 Million |
Martin Shkreli Earnings
He and his friend Marek Biestek started MSMB Capital Management in September 2009. He founded Retrophin under the MSMB umbrella and ran it as a portfolio company with an emphasis on biotechnology in 2011. He was chosen for the Forbes 30 Under 30 in November 2013.
View this post on Instagram
Social Media Links
| Click Here | |
| Click Here | |
| Click Here | |
| Click Here |
